ResearcherSir Run Run Shaw HospitalNo recent work listed

Meidan Ying

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0039-9683; OpenAlex author ID A5048115276. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Cucurbitacin C suppresses the progression of pancreatic ductal adenocarcinoma via inhibition of the cGMP-PKG-VASP axis. Co-author DOI 10.1016/j.bcp.2023.115810 ↗
Role of single nucleotide polymorphisms of DNA repair genes in susceptibility to pancreatic cancer in Chinese population. Co-author DOI 10.4238/gmr.15017273 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dongchao Xu · 1 shared paper, 2023 · strength 0.19
- Paper Cucurbitacin C suppresses the progression of pancreatic ductal adenocarcinoma via inhibition of the cGMP-PKG-VASP axis. DOI 10.1016/j.bcp.2023.115810 ↗
Qiang Liu · 1 shared paper, 2023 · strength 0.19
- Paper Cucurbitacin C suppresses the progression of pancreatic ductal adenocarcinoma via inhibition of the cGMP-PKG-VASP axis. DOI 10.1016/j.bcp.2023.115810 ↗
Xiaofeng Zhang · 1 shared paper, 2023 · strength 0.19
- Paper Cucurbitacin C suppresses the progression of pancreatic ductal adenocarcinoma via inhibition of the cGMP-PKG-VASP axis. DOI 10.1016/j.bcp.2023.115810 ↗
Hongzhang Shen · 1 shared paper, 2023 · strength 0.19
- Paper Cucurbitacin C suppresses the progression of pancreatic ductal adenocarcinoma via inhibition of the cGMP-PKG-VASP axis. DOI 10.1016/j.bcp.2023.115810 ↗
Ruihua Zhao · 1 shared paper, 2016 · strength 0.12
- Paper Role of single nucleotide polymorphisms of DNA repair genes in susceptibility to pancreatic cancer in Chinese populatio… DOI 10.4238/gmr.15017273 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.